within Pharmacolibrary.Drugs.ATC.B;

model B02BD07
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 0.243 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 35 / 1000000,
    adminCount     = 1,
    Vd             = 0.0437,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Coagulation factor XIII is a clotting factor essential for the final steps of the coagulation cascade by crosslinking fibrin. It is used as a replacement therapy in patients with factor XIII deficiency, a rare bleeding disorder. Factor XIII concentrates are approved for use today to treat and prevent bleeding in individuals with congenital factor XIII deficiency.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult subjects (mean age ~29 years, both sexes) following intravenous administration of recombinant factor XIII.</p><h4>References</h4><ol><li><p>Ponce, RA, et al., &amp; Rogge, MC (2005). Preclinical safety and pharmacokinetics of recombinant human factor XIII. <i>Toxicologic pathology</i> 33(4) 495–506. DOI:<a href=&quot;https://doi.org/10.1080/01926230490966247&quot;>10.1080/01926230490966247</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/16036868/&quot;>https://pubmed.ncbi.nlm.nih.gov/16036868</a></p></li><li><p>Adam, EH, et al., &amp; Wildenauer, R (2017). [Factor XIII : Pharmacodynamic and pharmacokinetic characteristics]. <i>Der Anaesthesist</i> 66(1) 52–59. DOI:<a href=&quot;https://doi.org/10.1007/s00101-016-0249-1&quot;>10.1007/s00101-016-0249-1</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/27942785/&quot;>https://pubmed.ncbi.nlm.nih.gov/27942785</a></p></li><li><p>Rodeghiero, F, et al., &amp; Castaman, G (1991). Clinical pharmacokinetics of a placenta-derived factor XIII concentrate in type I and type II factor XIII deficiency. <i>American journal of hematology</i> 36(1) 30–34. DOI:<a href=&quot;https://doi.org/10.1002/ajh.2830360107&quot;>10.1002/ajh.2830360107</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/1984679/&quot;>https://pubmed.ncbi.nlm.nih.gov/1984679</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end B02BD07;
